A working map, not a treatment plan.
These are informational offerings for people exploring ibogaine-related questions in Europe, alongside families, advocates, and policy-minded professionals seeking clear context. The starting point is the Ibogaine Europe overview, which frames the topic as a complex mix of evidence, regulation, risk, and practical uncertainty.
Ibogaine is a psychoactive alkaloid associated with the Tabernanthe iboga plant; that basic fact does not establish that any particular use, setting, or provider is safe. Our independent resource approach explains why careful language, source context, and visible uncertainty matter here.
“The useful question is often not ‘is it available?’ but ‘what can be responsibly known before a decision is made?’”